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This study examined the acute effects of combined tobacco smoking and exercise on 21 
immune-inflammatory responses in smoker populations with shorter or longer smoking 22 
history. The cohort comprised 14 young male adult (YSM) and 12 middle-aged (MSM) male 23 
active cigarette smokers matched for aerobic fitness and smoking behavior. Following an 24 
initial familiarization and baseline testing session, participant’s consumed two cigarettes 25 
(12mg tar, 1mg nicotine) within 15min,  followed by a 10min recovery period and then 26 
40min of cycling at 50% peak aerobic workload. Venous blood was obtained pre- and post-27 
protocol for analysis of interleukin (IL)-6, IL-1receptor antagonist (ra), IL-1beta (β) and 28 
monocyte chemoattractant protein-1 (MCP-1) and total leukocyte count. There were no 29 
significant baseline differences between age groups for IL-6 or MCP-1 (p>0.05), although 30 
higher basal IL-1ra was evident in YSM (p<0.05). Further, no significant differences existed 31 
between groups for post-exercise IL-1ra or IL-6 responses; though MSM demonstrated an 32 
elevated MCP-1 at 4h post (p<0.05). No between-group differences for total leukocyte count, 33 
platelets, neutrophils, lymphocytes or monocytes (p>0.05) were observed. However, higher 34 
concentrations of basophils immediately post and 4h  post-exercise, and higher eosinophils at 35 
4h post-exercise were evident in MSM (p<0.05). The current study highlights that prolonged 36 
elevations in MCP-1, alongside leukocytosis, accompany inhalation of tobacco smoke prior 37 
to exercise. Pre-exercise smoking may blunt the IL-1ra response to exercise in a smoker 38 
population, which in turn may be related to smoking history. 39 




Tobacco smoking is an addictive lifestyle behavior and has been associated with 42 
alterations in immune and inflammatory function. Despite a lack of clarity on the acute 43 
immune-inflammatory mechanisms, the long-term effects of tobacco smoking are well 44 
documented, with an increased risk for non-communicable diseases such as diabetes, 45 
cardiovascular disease and cancers amongst the most notable (Sopori, 2002; Yanbaeva et al., 46 
2007). Contrary to the effects of tobacco smoke, exercise offers protection against all-cause 47 
mortality, and produces favorable immune and inflammatory actions (Pedersen & Hoffman-48 
Goetz, 2008). Exercise has become increasingly more popular as a therapeutic intervention 49 
for mediating disease risk, further improving symptoms associated with chronic disease (Lee 50 
& Skerrett, 2001). However, it remains unknown as to whether the exercise-based responses 51 
provide an anti-inflammatory response to tobacco smoke. Further understanding of these 52 
potentially opposing effects of exercise and tobacco smoke on inflammatory responses may 53 
assist to determine whether exercise can be considered as a tool to reduce inflammatory states 54 
associated with long-term smoking. 55 
The mechanisms behind the physiological consequences of tobacco smoking are not 56 
well understood, though accumulating evidence suggests the adverse health outcomes from 57 
smoking may be related to alterations in immune function (Sopori & Kozak, 1998; Arson, 58 
Shoenfel, Amital, 2010; Sopori, 2002; Kastelein, Duffield & Marino, 2015). Long-term 59 
smoking is associated with augmentation of pro-inflammatory cytokines including, tumor 60 
necrosis factor- alpha (TNF-α), interleukins (IL)-1, IL-6, IL-8, granulocyte-macrophage 61 
colony-stimulating factor (GM-CSF) and subsequently inhibition of anti-inflammatory 62 
cytokines such as IL-10 (Arnson, Shoenfeld & Amital, 2010). Some of the reported effects 63 
from long-term smoking include reduced T-cell activity, augmented B-cell activity, activation 64 
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of leukocytes, decreased immunoglobulin’s and natural killer (NK) cells (Moszczynski et al., 65 
2001). The acute effects of tobacco smoke on immune and inflammatory processes also 66 
remain equivocal. Recently, we reported a singular bout of tobacco smoking alters the time-67 
course response of both interleukin-6 (IL-6) and monocyte chemoattractant protein- 1 (MCP-68 
1) (Kastelein, Duffield & Marino, 2015), which was related to duration of smoking history. 69 
Accordingly, given that habitual tobacco smoking imposes immune-inflammation alterations, 70 
including the up-regulation of IL-1β, IL-6 and TNF-α (Sopori, 2002), it seems important to 71 
determine the physiological responses to smoking exposure with differing smoking histories. 72 
 73 
In contrast to tobacco smoking, exercise promotes anti-inflammatory responses 74 
(Pedersen & Hoffman-Goetz, 2000). Specifically, a marked immune and inflammatory 75 
cellular influx accompanies an acute bout of exercise, with the magnitude of this cascade 76 
dependent upon physical stress induced from exercise intensity, duration and modality 77 
(Gleeson et al., 2011; Petersen & Pedersen, 2004). Anti-inflammatory cytokines including 78 
IL-6, IL-1ra and IL-10 and circulating leukocytes are amongst the myriad of cells induced by 79 
exercise stimulus and with regular exercise have been reported to produce favorable health 80 
outcomes and indeed, may offer protection against all-cause mortality (Gleeson et al., 2011). 81 
However, brief exposure to secondhand smoke compromises both the cardiorespiratory and 82 
immune responses to moderate-intensity exercise (Flouris et al., 2012), suggesting some 83 
interference in the exercise-induced inflammatory responses from smoke exposure. Despite 84 
the contrasting immune-inflammatory responses induced by exercise and smoking 85 
respectively, very few studies have examined whether one interferes with the other. 86 
 87 
 Given the significant alterations suggested to result from chronic tobacco smoking 88 
and the reported beneficial effects of exercise on immune function, it seems important to 89 
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determine the acute effects of tobacco smoking and exercise in a smoker population. Thus, 90 
this study aimed to aim to compare the immune-inflammatory responses to exercise and 91 
smoking in populations with longer or shorter smoking histories. 92 
 93 
Materials and Methods 94 
Subjects 95 
 96 
Young adult (n=14; 18-25y; YSM) and middle-aged (n=12; 30-50y; MSM) active 97 
cigarette smokers matched for fitness and smoking behavior (active smokers) were recruited. 98 
Participants reported as apparently healthy and were free of any metabolic or 99 
cardiopulmonary abnormalities or renal or hepatic disorders, immunological irregularities, 100 
abnormal leukocyte sub-populations, periodontal disease, and any other diseases or 101 
conditions associated with systemic inflammatory responses. The self-reported smoking 102 
history for the YSM and MSM populations was 5.2 ± 1.7y of smoking and 12.3 ± 6.8 103 
cigarettes per day and 14.6 ± 6.5y of smoking and 15.8 ± 7.3 cigarettes per day, respectively 104 
(Table 1). Prior to the commencement of the study, all participants were required to provide 105 
written and verbal consent following an outline of all procedures and measures. This study 106 
conformed to the Declaration of Helsinki and was approved by the Research in Human Ethics 107 
Committee at Charles Sturt University. 108 
 109 
Overview 110 
Prior to commencement of the study participants were required to complete pre-111 
exercise, health history and smoking questionnaires (healthy history questionnaire, 112 
Fagerstrom Test for Nicotine Dependence (Heatherton et al., 1991) and adult pre-exercise 113 
screening system (APSS). Following pre-screening, and if satisfying the inclusion criteria, 114 
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participants were enrolled into the study following provision of informed consent. 115 
Participants then completed an initial familiarization session prior to a baseline testing 116 
session, which included measures of anthropometry, a graded exercise test (GXT) and a dual-117 
energy x-ray absorptiometry scan. Following approximately 7d rest, participants returned to 118 
the laboratory and were required to partake in a testing session. The testing session involved 119 
the consumption of two cigarettes and following a 10min recovery the completion of a 120 
standardized cycle ergometry exercise protocol of 40min at 50% of peak oxygen 121 
consumption (VO2peak).   122 
 123 
Baseline Testing 124 
Participants reported to the laboratory between 0530h and 800h in a rested and fasted 125 
state for the baseline testing session, with all consent and health questionnaires completed 126 
prior to this session.  Stature (Stadiometer: Customised, Australia), body mass (HW 150 K, A 127 
& D, Bradford, MA, USA), and waist and hip circumferences (steel tape, EC P3 metric 128 
graduation, Australia) were obtained as measures of anthropometry based on standardized 129 
techniques. In addition, a supine dual-energy x-ray absorptiometry (DXA) scan was 130 
conducted for the determination of body composition (XR800, Norland, Cooper Surgical 131 
Company, Trumbull, CT, USA). Scanning resolution and speed were set at 6.5 x 13.0mm and 132 
130 mm.s-1, respectively. Whole body scans were analyzed (Illuminatus DXA, ver. 4.2.0, 133 
USA) for total body lean mass and total body fat mass and are reported in absolute (kg) and 134 
relative (%) terms. Participants were further fitted with a heart rate (HR) monitor (Rs800cx, 135 
Vantage NV, Polar, Finland) for the recording of HR. A baseline blood sample was collected 136 
to determine, resting concentrations of inflammatory markers and blood lipid profile 137 




Finally, a GXT was performed on an electronically-braked cycle ergometer (LODE 140 
Excalibur Sport, LODE BV, Groningen, The Netherlands) for the determination of VO2 peak. 141 
Pulmonary gas exchange was measured by determining O2 and CO2 concentrations and 142 
ventilation to calculate VO2 using a metabolic gas analysis system (Parvo-Medics, True2400, 143 
East Sandy, UT, USA). The younger group (YSM) commenced the test at 100W and increase 144 
by 25W whereas the middle-aged group (MSM) commenced at 25W and increase 25W every 145 
minute until every minute until volitional exhaustion. HR was collected every minute and a 146 
rating of perceived exertion (RPE: Modified Borg CR10 scale) collected at completion of the 147 
GXT.  148 
 149 
Pre-Exercise Cigarette Consumption 150 
Prior to the acute exercise bout, participants were instructed to smoke two cigarettes 151 
(Winfield Blue, 12mg tar, 1mg nicotine) within 15 minutes in a private but open area near the 152 
laboratory. Participants were seated throughout the protocol with no or minimal movements 153 
to ensure standardized measurements. The smoking protocol was based upon previous 154 
research by Van der Vaart et al., (2005) who administered two cigarettes of the same brand 155 
(two cigarettes of 12mg tar, 1mg nicotine) within 30min. Given that smoking is highly 156 
individualized and variable we standardized procedures in terms of dose and duration of the 157 
acute protocol. Participants were instructed to smoke as per normal smoking behaviour, 158 
adequacy of smoking ensured by visual observation by the research team.  Following a 10min 159 
seated rest after the consumption of both cigarettes participants commenced the exercise 160 
bout.  161 
 162 
Exercise Protocol 163 
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Following cigarette consumption, participants were required to complete the acute 164 
exercise protocol which consisted of 40min of stationary cycle ergometry (Monark 828E, 165 
Monark Exercise AB, Varburg, Sweden) at 50% of VO2peak. The workload was calculated as 166 
50% of the pedaling resistance (W) achieved during the GXT and was converted into 167 
kilopond units and set as a fixed intensity for the exercise protocol. Selection of this exercise 168 
protocol was based upon previous research (Mendham, Donges, Liberts & Duffield, 2011) 169 
that demonstrated an inflammatory response to a bout of exercise of the same intensity and 170 
duration as the current study, yet within the tolerable limits for the population. Further, 171 
telemetry-based HR (Rs800cx, Vantage NV, Polar, Finland) and RPE (Borg CR10 scale) 172 
were recorded every 5min and blood pressure was collected every 10min throughout and 173 
post-protocol. 174 
 175 
Blood Collection 176 
A 21-guage catheter inserted into the medial antecubital vein for the collection of 177 
venous blood will be collected pre and post (0min, 1h, 4h) protocol. Approximately, 50ml of 178 
blood was collected and aliquoted into serum separator tubes (SST) for analysis of blood lipid 179 
profile and CRP, ethylene diamine tetraacetic acid  (EDTA) tubes for analysis IL-6, IL-1ra, 180 
MCP-1, glycosylated haemoglobin (HbA1c), glucose and total and sub-population leukocyte 181 
count. EDTA tubes were centrifuged immediately at 3500rpm for 15min at 4oC and SST 182 
tubes were left to clot at room temperature for 20min prior to centrifugation. Supernatants 183 
were immediately stored at -80 oC or -20 oC for EDTA and SST, respectively. 184 
 185 
Blood Analysis 186 
Samples were analysed for blood lipid profile, CRP, IL-6, IL-1ra, MCP-1 and total 187 
and sub-population leukocyte count. Total cholesterol was analysed using an enzymatic 188 
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method and polychromatic endpoint technique measurement (Dimension Xpand Plus, 189 
Siemens Healthcare Diagnostics, Sydney, Australia). HDL cholesterol was measured using 190 
accelerator selective detergent methodology. Triglycerides were assessed using an enzymatic 191 
method and biochromatic endpoint technique measurement. Further, HbA1c was measured 192 
using automated high-performance liquid chromatography methodology (Bio-Rad Variant, 193 
Bio-Rad Laboratories, Sydney, Australia). Leukocyte count was determined by a cell counter 194 
(Sysmex XT-1800i, Mundelein, IL, USA). Moreover, concentrations of CRP were 195 
determined using a solid-phase, chemiluminescent immunometric assay and concentrations of 196 
IL-6, IL-1ra, MCP-1 and were analyzed with a sandwich enzyme immunoassay technique, 197 
according to manufacturer’s instructions (ELISAkit, Melbourne, Australia and Merk 198 
Millipore, Billerica, MA, USA). 199 
 200 
Statistical Analysis 201 
All data are reported as mean ± standard deviation (SD). Normal distribution was 202 
determined by Shapiro-Wilk’s test and non-normally distributed data (inflammatory data) 203 
was logarithmically transformed prior to analysis. Two-way repeated measures analysis of 204 
variance (ANOVA) was used to determine within- and between-group differences. Where a 205 
group interaction was noted, one-way ANOVA tests were applied to determine the source of 206 
significance. Significance was set at p<0.05. All statistical procedures were performed using 207 
Predictive Analytic Software (PASW) (Statistical Package for the Social Sciences for 208 
Windows version 18.0, Chicago, IL, USA).  209 
 210 
Results 211 
 Baseline data for blood lipid profile, anthropometric and smoking variables are 212 
reported in Table 1. No differences were observed between groups for VO2peak (p>0.05). The 213 
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MSM group demonstrated greater absolute and relative fat mass than YSM (p<0.05). In 214 
regards to smoking history, as expected the MSM group had significantly greater smoking 215 
history in terms of years of smoking and pack-years than YSM (p<0.05); however, this did 216 
not differ in regards to the number of cigarettes smoked or level of dependence (p>0.05) 217 
according to the Fagerstrom Test for Nicotine Dependence. Exercise-induced HR responses 218 
(% of HRmax) were not significantly different between groups (76.2 ± 8.3%, 77.8 ± 6.6% for 219 
YSM and MSM, respectively; p>0.05). Additionally, there were no significant differences in 220 
RPE between groups (5.0 ± 0.3 and 4.4± 0.3 for YSM, MSM, respectively; p>0.05).  221 
 222 
There were no baseline differences between groups for IL-6 or MCP-1 (p>0.05; 223 
Figure 1); however, YSM showed higher IL-1ra at baseline compared to MSM (p<0.05). No 224 
between group differences for IL-1ra or IL-6 were observed following exercise (p>0.05), 225 
although MSM demonstrated elevated MCP-1 at 4h post (p<0.05). Despite baseline 226 
differences for IL-1ra, no within-group change was observed for either group (p>0.05; Figure 227 
1). Post-exercise elevations in IL-6 were evident for YSM (p<0.05), though not for MSM 228 
(p>0.05). Post-exercise elevations in MCP-1 were observed for MSM, yet not in YSM, who 229 
showed a decline from 1h to 4h post-exercise (p<0.05). 230 
 231 
Total and fractional leukocyte responses are presented in Figure 2.  There were no 232 
between-group differences for total leukocyte count, platelets, neutrophils, lymphocytes or 233 
monocytes at baseline or following the protocol (p>0.05).  MSM showed higher 234 
concentrations of basophils at immediate post and 4h post-exercise, whilst eosinophils were 235 
higher elevated is MSM at 4h post-exercise (p<0.05). Both groups observed within-group 236 
post-exercise increases in WBC, which remained elevated at 4h post-protocol (p<0.05).  237 
Increased neutrophils counts were evident immediately post-protocol for YSM followed by a 238 
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decline to 1h (p<0.05). Similarly, MSM observed a decline to 1h followed by an increase to 239 
4h (p<0.05) in neurtophils, while platelet values for both groups remained above pre at 4h 240 
post (p<0.05). Both YSM and MSM showed a decrease from post to 1h in lymphocytes 241 
followed by an increase to 4h (p<0.05), and only values for YSM remained above pre 242 
(p<0.05). Monocytes increased post-exercise in MSM (p<0.05); however values for YSM 243 
were significantly higher at 4h than pre-values (p<0.05), which was not observed in MSM 244 
(p>0.05). The smoking and exercise protocol induced  declines in eosinophils  immediately 245 
post  to 1h in both groups, this decline continued to 4h for MSM and remained below pre-246 
values (p<0.05), not observed in YSM. Finally, basophils in both groups increased post 247 
exercise and declined thereafter (to 1h). 248 
 249 
Discussion 250 
This study examined the combined effects of acute tobacco smoking prior to exercise 251 
on inflammatory responses in smoker populations with longer or shorter smoking histories. 252 
Accordingly, the novel finding from this study is that IL-1ra remains relatively unchanged 253 
following both smoking and exercise stimulus, suggesting smoking to have a suppressive 254 
effect of the IL-1ra response to an acute bout of exercise. Furthermore, the chemokine MCP-255 
1 was significantly elevated at 4h post in MSM, which may be indicative of inflammatory 256 
cell recruitment resultant from the insult of tobacco smoke prior to exercise 257 
 258 
Chronic smoking results in significant alterations to the immune system (Sopori, 259 
2002; Mehta, Nazzal & Sadikot, 2008). As evidenced by the current study, even an acute 260 
bout of tobacco consumption has immune system implications. The current study revealed 261 
that pre-exercise smoking may inhibit the anti-inflammatory IL-1ra response to exercise, 262 
given IL-1ra remained unchanged, when previous research shows increased IL-1ra  following 263 
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an acute exercise bout (Moldoveanu, Shephard & Shek, 2001; Petersen & Pedersen, 2005). 264 
IL-1ra is known as an anti-inflammatory cytokine as it acts to inhibit the actions of IL-1 and 265 
ultimately IL-1β (Arend, 2002), and thus presents anti-inflammatory actions (Arend, 2002; 266 
Moldoveanu, Shephard & Shek, 2001). Accordingly, the present results suggest pre-exercise 267 
smoking may inhibit the anti-inflammatory IL-1ra response to exercise. Further, the present 268 
data contrasts with previous research indicating an IL-1ra response to acute exercise in young 269 
smokers delivered following an exercise bout (Kastelein et al. 2017). Given the differences in 270 
tobacco smoking timing, pre-exercise smoking may have an inhibitory effect on the IL-1ra 271 
response to exercise and thus counter the acute anti-inflammatory benefits derived from 272 
exercise. 273 
 274 
Accompanying the systemic inflammatory response is the presence of MCP-1, a 275 
potent chemoattractant. In the present study, a prolonged MCP-1 response in MSM was 276 
evident following the combination of smoking and exercise. Chemokines such as MCP-1 277 
control the expression and migration of cells such as neutrophils and lymphocytes, and while 278 
Becker, Seul & Lindemann (2005) observed increased MCP-1 following a maximal exercise, 279 
it is not uncommon for MCP-1 to be elevated in chronic tobacco smoking, with Traves et al. 280 
(2002) reported MCP-1 to be elevated in the pulmonary microenvironment in smokers at rest. 281 
Previous findings from our group revealed middle-aged smokers demonstrated elevated 282 
MCP-1 above that of age-matched non-smoking counterparts; and further, moderate-intensity 283 
exercise resulted in elevations in MCP-1 in both young and middle-aged smokers and their 284 
age-matched non-smoking counterparts (Kastelein, Duffield & Marino, 2015).  Further in 285 
response to an acute tobacco smoking bout, MCP-1 remained elevated for 4h post-286 
consumption in middle-aged smokers, whereas values declined for younger smokers 287 
(Kastelein, Duffield & Marino, 2015). Similarly, the present study revealed MCP-1 to be 288 
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elevated 4h post-protocol in MSM and not YSM. This finding may be as a consequence of 289 
the longer smoking history of the MSM group, and whilst speculative, alterations in the 290 
expression of MCP-1 resultant from chronic tobacco smoking may contribute to the 291 
development of low grade inflammatory states and consequently pathogenic events 292 
associated with long-term inflammation (Yadav, Saini & Arora, 2010). 293 
 294 
An acute bout of exercise generally causes a transient increase in IL-6 (Moldoveanu, 295 
Shephard & Shek, 2001), and smoking is suggested to cause perturbations in immune-296 
inflammatory function particularly in response to exercise as previously reported (Kastelein 297 
et al., 2017; Kastelein, Duffield & Marino, 2015). The current study showed no between-298 
group differences IL-6 responses. However, significant within-group elevations were 299 
observed for YSM and although following a similar pattern, values for MSM were not 300 
significant. As explanation, Koethe et al. (2000) reported cigarette smoke condensate to 301 
prime neutrophils thus making them more responsive to activating agent, additionally, primed 302 
neutrophils may function to amplify and prolong inflammation  (Koethe et al., 2000); 303 
however in MSM, inhibition of immune response may be a consequence of long term 304 
smoking (Stampfli & Anderson, 2009; Sopori, 2002). In the present study, elevations in IL-6 305 
for YSM are accompanied by neutrophilia, and Suzuki et al. (1999) previously proposes 306 
exercise induced neurtophilia may be in part responsible for the inflammatory response. 307 
These mechanism may be in part responsible for the IL-6 responses in YSM, and while were 308 
not measured here, the elevations in IL-6 may result from neutrophil priming amongst YSM 309 
in response to an acute bout of smoking and exercise. 310 
 311 
  Leukocytosis following an acute bout of exercise is well known (Gabriel & 312 
Kindermann, 1997; Suzuki et al., 2000). Similarly, it is commonly reported for chronic 313 
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smokers to exhibit leukocytosis as a result of long term cigarette smoke exposure (Frohlich et 314 
al., 2003; Kawada, 2004). However, minimal literature exists describing whether smoking 315 
exacerbates the leukocyte response to exercise following acute smoke exposure. 316 
This study showed that smoking followed by an acute exercise bout induced elevations in 317 
basophils and eosinophils in MSM at 1h and WBC remained elevated at 4h, this is in contrast 318 
to our previous work, which suggest post-exercise tobacco smoking results in decreases in 319 
eosinophils and basophils (Kastelein et al., 2017). Interestingly, the elevated in WBC count 320 
are paralleled in prolonged elevations in MCP-1, particularly amongst MSM. Given MCP-1 321 
is a chemoattractant, it is plausible to suggest that the physiological stress of smoking and 322 
exercise results in inflammatory cell recruitment; which, may provide insight to the 323 
mechanisms responsible for low grade inflammation observed in tobacco smokers (Yadav, 324 
Saini & Arora, 2010).  325 
 326 
The addictive nature of tobacco smoke contributes to multiple tobacco-induced 327 
pathological states, of which immune-inflammatory mechanisms may play a role. While 328 
numerous studies report the immune and inflammatory response to smoking and exercise 329 
respectively (Moldoveanu, Shephard & Shek, 2000; Yanbaeva et al., 2008; Arnson, 330 
Shoenfeld & Amital, 2010), concurrent smoking and exercise responses remain relatively 331 
unknown. Pre-exercise smoking responses here show reduction in the post-exercise IL-1ra 332 
response, suggesting that smoking prior to exercise inhibits the anti-inflammatory response to 333 
an acute exercise bout. Further, the current study suggests that prolonged elevations in MCP-334 
1, alongside leukocytosis, which may be indicative of pathological changes amongst MSM. 335 
These findings contribute to the understanding on the mechanisms responsible for the 336 
physiological consequences of smoking, further, examines the role of exercise as a tool for 337 
improving the health of smokers. While the current findings suggests that concurrent 338 
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smoking and exercise may inhibit the anti-inflammatory response to exercise future research 339 
should be directed toward  smoking cessation and exercise programs, given the purported 340 
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Table 1. Mean ± SD Baseline descriptive, anthropometric, dual-energy x-ray absorptiometry (DXA), 
biochemistry, aerobic fitness and smoking variables within the young smoker (n=14) and  middle-aged smoker 
(n=14) populations. 





Age (years) 22.0 ± 1.57 33.27 ± 7.75* 
 
Height (m) 1.82 ± 0.07 1.77 ± 0.07 
 
Weight (kg) 81.78 ± 12.07 81.22 ±12.87 
 
VO2 peak (mL.kg-1.min-1) 36.67 ± 3.06 33.93 ± 8.74 
 
Final stage Watts (GXT) 275 ± 36.69 230 ± 46.48 
 
Waist Circumference (cm) 84.46 ± 8.44 87.67 ± 8.92 <102 
Waist to hip ratio 0.86 ± 0 .05 0.86 ± 0.06 <0.90 
% Fat mass 15.62 ± 5.78 24.75 ± 6.76* 
 
Lean Mass (kg) 63.03 ± 9.05 59.02 ±6.61 
 
Fat Mass (kg) 12.37 ± 5.32 20.68 ± 6.83* 
 
Biochemistry 
    
 
CRP  2.0 ± 1.90 
 
1.98 ± 1.80 <2.9 
HDL (mmol L-1) 1.06 ± 0.34 1.22 ±  0.36 >1.0 
Triglycerides (mmol L-1) 1.28 ± .064 1.50 ± 0.84 <2.0 
Fasting glucose (mmol L-1) 5.07 ± 0.73 4.79 ± 0.46 <5.5 
HbA1c (%A1c) 5.20 ± 0.31 5.48 ± 0.28 <6.5 
Smoking Variables 
    
 
Years of smoking 5.21 ± 1.72 14.62 ± 6.55* 
 
Cigarettes per day 12.31 ± 6.81 15.79 ± 7.34 
 
Pack years 2.86 ± 1.91 12.15 ± 9.61* 
 
Fagerstrom score 2.31 ± 1.38 2.48 ± 1.28 
 
  





Fig. 1. Mean ± SD for IL-1ra, IL-6 and MCP-1 pre, post, 1h and 4h post protocol for younger 459 
smokers and older smokers. * represents significantly different between YSM and MSM 460 
(P<0.05), # represents significantly different within condition for YSM (P<0.05), ¥ represents 461 
significantly different within condition for MSM (P<0.05). 462 
 463 
 464 
Fig. 2. Mean ± SD for total and fractional leukocytes pre, post, 1h and 4h post protocol for 465 
younger smokers and older smokers. * represents significantly different between YSM and 466 
MSM (P<0.05), # represents significantly different within condition for YSM (P<0.05), ¥ 467 
represents significantly different within condition for MSM (P<0.05). 468 
 469 
